Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial

Fig. 3

Plasma glucose (PG), immune reactive insulin (IRI), and triglyceride (TG) levels during cookie meal test at baseline and 6 months. Bars indicate SEM. * indicates P < 0.05 vs baseline. Comparisons of data between before and after treatment were performed using a paired t test

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840